Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TOP2A | P11388 | 1/20 | 0.30 |
| ▸ | NQO2 | P16083 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31683840 | 1.00 | TDP1 (0.39) | TDP1KDM4EPKMKDRMAPT | |
| SCHEMBL23353119 | 0.77 | PDE4A (0.41) | TDP1KDM4EPKMMAPTALDH1A1 | |
| SCHEMBL23353111 | 0.72 | MEN1 (0.36) | TDP1KDM4EMAPTHSD17B10ALDH1A1 | |
| SCHEMBL23352655 | 0.72 | MEN1 (0.39) | TDP1KDM4EPKMMAPTHSD17B10 | |
| SCHEMBL23353052 | 0.72 | MEN1 (0.39) | TDP1KDM4EPKMMAPTHSD17B10 | |
| SCHEMBL23353160 | 0.72 | MEN1 (0.39) | TDP1KDM4EPKMMAPTHSD17B10 | |
| SCHEMBL23327604 | 0.69 | MEN1 (0.39) | TDP1KDM4EMAPTHSD17B10ALDH1A1 | |
| SCHEMBL23353295 | 0.69 | MEN1 (0.33) | KDM4EMAPTALDH1A1RAB9AKMT2A | |
| SCHEMBL23353275 | 0.69 | MEN1 (0.36) | TDP1KDM4EMAPTHSD17B10ALDH1A1 | |
| SCHEMBL11477655 | 0.67 | MAPT (0.49) | KDM4EKDRMAPTHSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | SK MATERIALS CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | SK MATERIALS CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | L1CAM, EML4, OCIAD2 | TDP1 3129/4885KDM4E 3234/4885PKM 3700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.